VYGR Market Cap History
Below is a table of the VYGR market cap history going back to 11/11/2015:

Date VYGR Market Cap
11/11/2015456.57M
12/15/2015561.73M
3/14/2016268.56M
5/6/2016325.01M
8/5/2016431.13M
11/7/2016319.57M
3/10/2017328.36M
5/5/2017247.85M
8/4/2017233.26M
10/30/2017612.56M
3/9/2018866.04M
5/4/2018606.67M
8/3/2018627.96M
11/2/2018460.35M
2/22/2019427.94M
5/3/2019829.10M
8/2/2019785.95M
11/1/2019598.73M
2/28/2020404.97M
5/1/2020393.48M
8/5/2020404.63M
11/4/2020443.59M
2/19/2021253.79M
5/5/2021161.48M
8/4/2021120.64M
10/28/2021139.68M
3/2/2022148.27M
4/29/2022281.88M

Also see: VYGR Shares Outstanding History
and VYGR YTD Return
VYGR Historical Market Cap:
-7.19% CAGR
VYGR Historical Market Cap: +-7.19% CAGR

Mouse over chart for data details
11/11/2015 ...4/29/2022
Voyager Therapeutics is a gene therapy company focused on developing treatments and platform technologies. Co.'s team has developed a proprietary adeno-associated virus (AAV) capsid discovery platform called TRACER™ (Tropism Redirection of AAV by Cell Type-Specific Expression of RNA) to facilitate the selection of AAV capsids with blood brain barrier crossing and cell-specific transduction properties for particular therapeutic applications. The TRACER discovery platform is a functional RNA-based AAV capsid discovery platform that allows for rapid in vivo evolution of AAV capsids with cell-specific transduction properties in multiple species, including non-human primates. We show 28 historical shares outstanding datapoints in our VYGR shares outstanding history coverage, used to compute VYGR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VYGR market cap history over the course of time is important for investors interested in comparing VYGR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VYGR versus a peer is one thing; comparing VYGR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VYGR can fluctuate over the course of history. With this page we aim to empower investors researching VYGR by allowing them to research the VYGR market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree VYGR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Voyager Therapeutics (VYGR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

VYNE Market Cap History
VYNT Market Cap History
WAT Market Cap History
WCG Market Cap History
WINT Market Cap History
WMGI Market Cap History
XAIR Market Cap History
XBIO Market Cap History
XCUR Market Cap History
XENT Market Cap History
More Healthcare companies »

 

VYGR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.